The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy

Table 2

Difference of critical clinical and pathological characteristics between groups.

Characteristics	Number; Complete metastasectomy	Number; Incomplete metastasectomy	Number; No metastasectomy	value
Gender
Male	28	9	41	0.262
Female	3	2	13
Years
65 or more	9	3	14	0.953
Less than 65	22	8	40
Pathology
Clear cell carcinoma	31	10	49	0.217
Others	0	1	5
T
T1-2	18	6	31	0.979
T3-4	13	5	23
N
N0	30	11	46	0.111
N1-2	1	0	8
G
G1-2	18	8	42	0.155
G3-4	13	3	12
DFI
12 months or less	17	9	27	0.154
More than 12 months	14	2	27
Metastatic organ
1	25	5	31	0.042
≥2	6	6	23

Statistically significant.